标题
Parkinson disease
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROLOGY
Volume 27, Issue 1, Pages 27-42
出版商
Wiley
发表日期
2019-10-21
DOI
10.1111/ene.14108
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prodromal Parkinson's Disease: The Decade Past, the Decade to Come
- (2019) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
- (2019) Alan Whone et al. BRAIN
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Challenges in the diagnosis of Wilson disease
- (2019) Aurélia Poujois et al. Annals of Translational Medicine
- Update of the MDS research criteria for prodromal Parkinson's disease
- (2019) Sebastian Heinzel et al. MOVEMENT DISORDERS
- LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
- (2018) Marialuisa Quadri et al. LANCET NEUROLOGY
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
- (2018) Emily M. Rocha et al. NEUROBIOLOGY OF DISEASE
- Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications
- (2018) Roberta Balestrino et al. NEUROSCIENTIST
- Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
- (2018) Delphine Charvin et al. NATURE REVIEWS DRUG DISCOVERY
- Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
- (2018) Lindsay Joy Spielman et al. NEUROCHEMISTRY INTERNATIONAL
- Atypical parkinsonian syndromes: a general neurologist's perspective
- (2017) A. B. Deutschländer et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
- (2017) Roberta Balestrino et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
- (2017) Tim E. Moors et al. Molecular Neurodegeneration
- Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society
- (2017) Kailash P. Bhatia et al. MOVEMENT DISORDERS
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Non-motor features of Parkinson disease
- (2017) Anthony H.V. Schapira et al. NATURE REVIEWS NEUROSCIENCE
- Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
- (2017) Fabrizio Stocchi et al. NEUROLOGY
- Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis
- (2017) Azin Shafieesabet et al. PARKINSONISM & RELATED DISORDERS
- β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
- (2017) Shuchi Mittal et al. SCIENCE
- VPS35, the Retromer Complex and Parkinson’s Disease
- (2017) Erin T. Williams et al. Journal of Parkinsons Disease
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Anthony H. V. Schapira et al. JAMA Neurology
- Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease
- (2017) Antonio Martin-Bastida et al. Scientific Reports
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- How strong is the evidence that Parkinsonʼs disease is a prion disorder?
- (2016) Patrik Brundin et al. CURRENT OPINION IN NEUROLOGY
- Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease
- (2016) Robert A. Hauser et al. MOVEMENT DISORDERS
- Parkinsonism, movement disorders and genetics in frontotemporal dementia
- (2016) José Fidel Baizabal-Carvallo et al. Nature Reviews Neurology
- Epidemiology of Parkinson Disease
- (2016) Andrea Lee et al. NEUROLOGIC CLINICS
- Advances in levodopa therapy for Parkinson disease
- (2016) Rohit Dhall et al. NEUROLOGY
- Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis
- (2016) Shuang Bai et al. PLoS One
- Association between Parkinson’s Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis
- (2016) Charles B. Breckenridge et al. PLoS One
- Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
- (2015) Ziv Gan-Or et al. Autophagy
- Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease
- (2015) Daphne Robakis et al. CNS DRUGS
- Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
- (2015) Thomas Müller DRUGS
- Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease
- (2015) Karl Kieburtz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lewy body dementias
- (2015) Zuzana Walker et al. LANCET
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Development of Passive Immunotherapies for Synucleinopathies
- (2015) Ann-Louise Bergström et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease
- (2015) Leo Verhagen Metman et al. MOVEMENT DISORDERS
- Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
- (2015) Lisa Klingelhoefer et al. Nature Reviews Neurology
- Atypical Parkinsonism
- (2015) Maria Stamelou et al. NEUROLOGIC CLINICS
- Mechanism of Deep Brain Stimulation
- (2015) Satomi Chiken et al. NEUROSCIENTIST
- Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis
- (2015) Patompong Ungprasert et al. PARKINSONISM & RELATED DISORDERS
- Huntington disease
- (2015) Gillian P. Bates et al. Nature Reviews Disease Primers
- Sex differences in Parkinson’s disease
- (2014) Glenda E. Gillies et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
- (2014) Gennaro Pagano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Behavioral effects of levodopa
- (2014) Isabelle Beaulieu-Boire et al. MOVEMENT DISORDERS
- Differentiating drug-induced parkinsonism from Parkinson's disease: An update on non-motor symptoms and investigations
- (2014) Francesco Brigo et al. PARKINSONISM & RELATED DISORDERS
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
- (2014) et al. JAMA Neurology
- Inhaled dry powder apomorphine (VR040) for ‘off ’ periods in Parkinson's disease: an in-clinic double-blind dose ranging study
- (2013) K. A. Grosset et al. ACTA NEUROLOGICA SCANDINAVICA
- Parkinson's disease and risk of mortality: meta-analysis and systematic review
- (2013) J. Xu et al. ACTA NEUROLOGICA SCANDINAVICA
- Dopamine receptor agonists for Parkinson's disease
- (2013) Fabio Blandini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Nonmotor symptoms and health-related quality of life in early Parkinson's disease
- (2013) Pablo Martinez-Martin MOVEMENT DISORDERS
- How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale
- (2013) Glenn T. Stebbins et al. MOVEMENT DISORDERS
- Dangerous duet: LRRK2 and α-synuclein jam at CMA
- (2013) Zhenyu Yue et al. NATURE NEUROSCIENCE
- Neurostimulation for Parkinson's Disease with Early Motor Complications
- (2013) W.M.M. Schuepbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease
- (2012) A. Berardelli et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
- (2012) Koichi Wakabayashi et al. MOLECULAR NEUROBIOLOGY
- Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease
- (2012) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Caffeine and risk of Parkinson's disease in a large cohort of men and women
- (2012) Natalia Palacios et al. MOVEMENT DISORDERS
- Role of DaTSCAN and clinical diagnosis in Parkinson disease
- (2012) R. de la Fuente-Fernandez NEUROLOGY
- Amantadine: The journey from fighting flu to treating Parkinson disease
- (2012) G. Hubsher et al. NEUROLOGY
- Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration
- (2012) B. Dehay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
- (2011) Tito Calì et al. BIOFACTORS
- Levodopa–carbidopa intestinal gel for treatment of advanced Parkinson’s disease
- (2011) H.H. Fernandez et al. CURRENT MEDICAL RESEARCH AND OPINION
- NSAID use and risk of Parkinson disease: a population-based case-control study
- (2011) C. Becker et al. EUROPEAN JOURNAL OF NEUROLOGY
- Meta-analysis of123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders
- (2011) Alisha E. King et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- A Pathologic Cascade Leading to Synaptic Dysfunction in -Synuclein-Induced Neurodegeneration
- (2010) D. A. Scott et al. JOURNAL OF NEUROSCIENCE
- Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis
- (2010) J. J. Gagne et al. NEUROLOGY
- α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra
- (2010) Alison L. McCormack et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More